- Home
- ICLR vs TRNO Comparison
ICLR vs TRNO Comparison
Compare ICLR & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICLR | TRNO |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.4B |
| IPO Year | 2001 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ICLR | TRNO |
|---|---|---|
| Price | $172.48 | $65.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $178.62 | $67.83 |
| AVG Volume (30 Days) | ★ 532.6K | 524.0K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | N/A | ★ 103.65 |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $476,383,000.00 |
| Revenue This Year | N/A | $8.42 |
| Revenue Next Year | N/A | $9.10 |
| P/E Ratio | ★ $12.91 | $54.79 |
| Revenue Growth | N/A | ★ 24.51 |
| 52 Week Low | $66.57 | $55.94 |
| 52 Week High | $203.91 | $78.94 |
Technical Indicators
Market Signals| Indicator | ICLR | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 29.62 |
| Support Level | $162.06 | $63.42 |
| Resistance Level | $183.11 | $67.18 |
| Average True Range (ATR) | 5.66 | 1.01 |
| MACD | -0.90 | -0.18 |
| Stochastic Oscillator | 34.81 | 1.83 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.